Aquestive Therapeutics (AQST) Interest Coverage Ratio: 2017-2024
Historic Interest Coverage Ratio for Aquestive Therapeutics (AQST) over the last 8 years, with Dec 2024 value amounting to -2.77.
- Aquestive Therapeutics' Interest Coverage Ratio fell 38.52% to -4.13 in Q3 2025 from the same period last year, while for Sep 2025 it was -5.02, marking a year-over-year decrease of 152.37%. This contributed to the annual value of -2.77 for FY2024, which is 16.09% down from last year.
- According to the latest figures from FY2024, Aquestive Therapeutics' Interest Coverage Ratio is -2.77, which was down 16.09% from -2.38 recorded in FY2023.
- In the past 5 years, Aquestive Therapeutics' Interest Coverage Ratio ranged from a high of -2.38 in FY2023 and a low of -6.42 during FY2022.
- For the 3-year period, Aquestive Therapeutics' Interest Coverage Ratio averaged around -3.86, with its median value being -2.77 (2024).
- Per our database at Business Quant, Aquestive Therapeutics' Interest Coverage Ratio crashed by 86.04% in 2022 and then spiked by 62.88% in 2023.
- Aquestive Therapeutics' Interest Coverage Ratio (Yearly) stood at -3.88 in 2020, then increased by 10.98% to -3.45 in 2021, then slumped by 86.04% to -6.42 in 2022, then surged by 62.88% to -2.38 in 2023, then fell by 16.09% to -2.77 in 2024.